ARCHIVES

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

This article is from The Cancer Letter archive.

Vol. 03 No. 35 | September 2, 1977

Download PDF Visit The Full Archive

Related Articles

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

Program Announcement: Breast Cancer Research

May 28, 1993

No difference between digital or film mammograms, study finds.

September 23, 2005

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004